Mark Ettel
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cardiac Structural Anomalies and Repair
- Pediatric Hepatobiliary Diseases and Treatments
Papers in
- Surgery 8
- Helicobacter pylori-related gastroenterology studies 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Ruliang Xu (3 shared papers)Monvadi B. Srichai (1 shared paper)Muhamed Sarić (2 shared papers)Leon Axel (1 shared paper)James S. Babb (1 shared paper)Ruth Lim (1 shared paper)Rima Patel (1 shared paper)Ambika C. Nayar (1 shared paper)
- Journals
- Human Pathology (3 papers)The American Journal of Gastroenterology (2 papers)American Journal of Clinical Pathology (1 paper)Diagnostic Pathology (1 paper)Histopathology (1 paper)
- Partner nations
- United StatesSwedenAustralia
In The Last Decade
Mark Ettel
25 papers receiving 294 citations
Peers
Comparison fields: 5 of 62
- Hepatology 24
- Surgery 112
- Oncology 69
- Pharmacology 20
- Cardiology and Cardiovascular Medicine 40
Countries citing papers authored by Mark Ettel
This map shows the geographic impact of Mark Ettel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ettel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ettel more than expected).
Fields of papers citing papers by Mark Ettel
This network shows the impact of papers produced by Mark Ettel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ettel. The network helps show where Mark Ettel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ettel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 72 | |
| 2 | 2015 | 45 | |
| 3 | 2019 | 36 | |
| 4 | 2017 | 18 | |
| 5 | 2019 | 17 | |
| 6 | 2015 | 16 | |
| 7 | 2018 | 14 | |
| 8 | 2024 | 13 | |
| 9 | 1999 | 13 | |
| 10 | 2016 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2018 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2017 | 2 |
About Mark Ettel
Mark Ettel is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 29 papers that have together received 302 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Cardiac tumors and thrombi (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Cancer-related molecular mechanisms research (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hepatology (24 citations), Surgery (112 citations), Oncology (69 citations), Pharmacology (20 citations) and Cardiology and Cardiovascular Medicine (40 citations). Mark Ettel has collaborated with scholars based in United States, Sweden and Australia. Frequent co-authors include Ruliang Xu, Monvadi B. Srichai, Muhamed Sarić, Leon Axel, James S. Babb, Ruth Lim, Rima Patel, Ambika C. Nayar, Roland Hilgarth and Anny‐Claude Luissint. Their work appears in journals such as Human Pathology, The American Journal of Gastroenterology, American Journal of Clinical Pathology, Diagnostic Pathology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.